Regeneron Investor
Regeneron Pharmaceuticals is a biotechnology company that invents life-transforming medicines for people with serious diseases.
Founded Date:
1988-01-01
Total Funding:
8900000.0
Technology:
Others
Last Funding Type:
Post-IPO Equity
Acquisitions Number:
Made Acquisitions
Investors Number:
NA
Last Funding Date:
2016-08-22
Zip:
NA
Industry:
Biopharma
Headquarters:
Tarrytown, New York, United States
Estimated Revenue:
$1B to $10B